Aisha Abdullah received a B.S. in biology from the University of Houston and a Ph.D. in neuroscience from Weill Cornell Medical College, where she studied the role of microRNA in embryonic and early postnatal brain development. Since finishing graduate school, she has worked as a science communicator making science accessible to broad audiences.
An analysis using machine learning identified distinct patient groups and disease activity trajectories among young patients in the U.K. with juvenile idiopathic arthritis (JIA). Its findings revealed that nearly a quarter of ... Read more
A large-scale genome analysis has identified five genetic variants newly associated with disease susceptibility in multiple subtypes of juvenile idiopathic arthritis (JIA). The analysis also revealed several genes potentially involved ... Read more
Previous Epstein-Barr virus (EBV) infection is associated with increased disease activity and impaired response to treatment in children with juvenile idiopathic arthritis (JIA), a recent study has found. The study, “The Impact of ... Read more
Variations in single nucleotides — the building blocks of DNA — in two genes may help predict the safety and efficacy of methotrexate (MTX) treatment in individual children with juvenile idiopathic ... Read more
Health Canada has expanded the approved use of Brenzys, a biosimilar of Enbrel (etanercept), to include the treatment of juvenile idiopathic arthritis (JIA) and other inflammatory disorders. Brenzys is now indicated ... Read more